1.
Olszewski J, Kozon K, Sitnik M, Herjan K, Mikołap K, Gastoł B, et al. Mirikizumab – a new option in the treatment of inflammatory bowel diseases. Prosp. Pharm. Sc. [Internet]. 2024 Sep. 23 [cited 2024 Dec. 11];22(3):178-85. Available from: https://prospects.wum.edu.pl/index.php/pps/article/view/262